- Home
- MRVI vs AWP Comparison
MRVI vs AWP Comparison
Compare MRVI & AWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- AWP
- Stock Information
- Founded
- MRVI 2014
- AWP 2007
- Country
- MRVI United States
- AWP United States
- Employees
- MRVI N/A
- AWP N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- AWP Trusts Except Educational Religious and Charitable
- Sector
- MRVI Health Care
- AWP Finance
- Exchange
- MRVI Nasdaq
- AWP Nasdaq
- Market Cap
- MRVI 312.4M
- AWP 335.3M
- IPO Year
- MRVI 2020
- AWP N/A
- Fundamental
- Price
- MRVI $2.67
- AWP $3.84
- Analyst Decision
- MRVI Hold
- AWP
- Analyst Count
- MRVI 10
- AWP 0
- Target Price
- MRVI $6.84
- AWP N/A
- AVG Volume (30 Days)
- MRVI 1.9M
- AWP 331.5K
- Earning Date
- MRVI 08-06-2025
- AWP 01-01-0001
- Dividend Yield
- MRVI N/A
- AWP 12.48%
- EPS Growth
- MRVI N/A
- AWP N/A
- EPS
- MRVI N/A
- AWP N/A
- Revenue
- MRVI $241,856,000.00
- AWP N/A
- Revenue This Year
- MRVI N/A
- AWP N/A
- Revenue Next Year
- MRVI $10.62
- AWP N/A
- P/E Ratio
- MRVI N/A
- AWP N/A
- Revenue Growth
- MRVI N/A
- AWP N/A
- 52 Week Low
- MRVI $1.67
- AWP $3.06
- 52 Week High
- MRVI $10.03
- AWP $4.20
- Technical
- Relative Strength Index (RSI)
- MRVI 59.30
- AWP 39.61
- Support Level
- MRVI $2.52
- AWP $3.86
- Resistance Level
- MRVI $2.93
- AWP $3.94
- Average True Range (ATR)
- MRVI 0.18
- AWP 0.05
- MACD
- MRVI 0.03
- AWP -0.01
- Stochastic Oscillator
- MRVI 69.41
- AWP 23.53
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About AWP abrdn Global Premier Properties Fund of Beneficial Interest
Aberdeen Global Premier Properties Fund is a diversified, closed-end management investment company. Its objective is to seek high current income and capital appreciation. It predominantly invests in equity and debt securities of domestic and foreign issuers which are principally engaged in the real estate industry, real estate financing or control real estate assets. Its portfolio of investments consists securities of Industrial REITs, Retail REITs, Data Center REITs, Health Care REITs and others.